GLP-1 and SGLT2 Users Face Different Risk for Diabetic Foot Complication

(MedPage Today) -- CHICAGO--Use of GLP-1 receptor agonists was tied to significantly lower risks of major diabetic foot complications compared with SGLT2 inhibitors in adults with type 2 diabetes, a large, real-world analysis indicated.
Compared...